This new license is an important step forward in bringing a new drug therapy closer to patients living with diabetes as it will enable us to access a promising lead […]
VANCOUVER and TORONTO, Canada (September 9, 2016) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, has […]
The World Health Organization (WHO) has marked April 7, 2016 as World Health Day. The focus of this year’s theme is diabetes. The number of people living with diabetes has […]
VANCOUVER, BC (February 2, 2016) — The Centre for Drug Research and Development (CDRD) announced today that two of its spin-off companies, Zucara Therapeutics and Sepset Biosciences, have been chosen to present […]
TORONTO and VANCOUVER, CANADA (January 12, 2016) — A novel drug therapy to reduce the severity and frequency of hypoglycemic (low blood sugar) episodes in people with diabetes is being […]